Common Variable immunodeficiency disorders: Division into distinct clinical phenotypes

Blood

Volumn 112, Issue 2, 2008, Pages 277-286

  Chapel, Helen ^a,j   Lucas, Mary ^a   Lee, Martin ^b   Bjorkander, Janne ^c   Webster, David ^d   Grimbacher, Bodo ^d,e   Fieschi, Claire ^f   Thon, Vojtech ^g   Abedi, Mohammad R ^h,i   Hammarstrom, Lennart ⁱ  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF FREIBURG   (Germany)

^f SAINT LOUIS HOSPITAL   (France)

^g MASARYK UNIVERSITY   (Czech Republic)

^h ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN CLASS;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL INFILTRATION; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; BLOOD; CANCER INVASION; CD8+ T LYMPHOCYTE; CLASSIFICATION; CLINICAL TRIAL; COHORT ANALYSIS; IMMUNOLOGY; MULTICENTER STUDY; ONSET AGE; PATHOLOGY; PROGNOSIS; REGISTER;

AGE OF ONSET; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; COMMON VARIABLE IMMUNODEFICIENCY; HUMANS; IMMUNOGLOBULIN ISOTYPES; LEUKEMIC INFILTRATION; PHENOTYPE; PROGNOSIS; REGISTRIES;

EID: 47649102955     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-11-124545     Document Type: Article

References (42)

1. Geha R, Notarangelo LD, Casanova JL, et al, International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007;120:776-794.
2. Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34-48.
3. van Zelm M, Reisli I, van der Burg M, et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med. 2006;354:1901-1912.
4. Salzer U, Maul-Pavicic A, Cunningham-Rundles C, et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol. 2004; 113:234-240.
5. Pan-Hammarstrom Q. Salzer U, Du L, et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet. 2007;39:429-430.
6. Sekine H, Ferreira, RC, Pan-Hammarstrom Q, et al. Role for Msh5 in the regulation of Ig class switch recombination. Proc Natl Acad Sci USA. 2007;104:7193-7198.
7. Eastwood D, Gilmour KC, Nistala K, et al. Prevalence of SAP gene defects in male patients diagnosed with common variable immunodeficiency. Clin Exp Immunol. 2004;137:584-588.
8. Spickett GP, Webster AD, Farrant J. Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev. 1990:2:199-219.
9. Notarangelo L, Casanova JL, Conley ME, et al, International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol. 2006;117:883-896.
10. Durandy A, Revy P, Fischer A. Autosomal hyperIgM syndromes caused by an intrinsic B cell defect. In: Ochs, H, Smith CIE, Puck, JM. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. New York: Oxford University Press. 2007;269-278.
11. Farrant J. T and B cell defects in common variable immunodeficiency. Immunol Invest. 1991;20: 143-150.
12. Goldacker S, Draeger R, Warnatz K, et al. Active vaccination in patients with common variable immunodeficiency (CVID). Clin Immunol. 2007;124: 294-303.
13. Warnatz K, Denz A, Dräger R, et al. Severe deficiency of switched memory B cells (CD27+IgMIgD-) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood. 2002; 99:1544-1551.
14. Carsetti R, Rosado MM, Donnanno S, et al. The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol. 2005;115:412-417.
15. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adultonset common variable immunodeficiency. Nat Immunol. 2003;4:261-268.
16. Moratto DGA, Fontana S. Mori L, et al. Combined decrease of defined B and T cell subsets in a group of common variable immunodeficiency patients. Clin Immunol. 2006;121:203-214.
17. Alachkar H, Taubenheim N. Haeney MR, Durandy A, Arkwright PD. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. Clin Immunol. 2006;120:310-318.
18. Healy M, for the Medical Research Council working party on hypogammaglobulinaemia. Hypogammaglobulinaemia in the United Kingdom: XII Statistical analyses: prevalence, mortality and effects of treatment. Special Report Series of the Medical Research Council (GB). 1971;310:115-123.
19. Quinti I, Soresina A, Sparado G, etal. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol. 2007;27:308-316.
20. Conley M, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies: representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol. 1999;93: 190-197.
21. Government Actuary's Department. Historic interim life tables. http://www.gad.gov. uk/Demography-Data/Life-Tables/HistoricalJnterim-life- tables.asp. Accessed January 12, 2008.
22. Hermaszewski R, Webster ABD. Primary hypogammaglobulinaemia: a survery of clinical manifestations and complications. Q J Med. 1993;86: 31-42.
23. Aghamohammadi AFA, Moin M, Rezaei N, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diag Lab Immunol. 2005;12:825-832.
24. Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O. Pulmomary abnormalities in patients with primary hypogammaglobulinaemia. J Allergy Clin Immunol. 1999;104: 1031-1036.
25. Kokron CM, Errante PR, Barros MT, et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc. 2004:76: 707-726.
26. Morrell D, Chase CL, Swift M. Cancer and autoimmune disease in families with common variable immune deficiency. Genet Epidemiol. 1986;3:17-26.
27. Muscaritoli M, Fanfarillo F, Luzi G, et al. Impaired nutritional status in common variable immunodeficiency patients correlates with reduced levels of serum IgAand of circulating CD4+ T lymphocytes. Eur J Clin Invest. 2001;31:544-549.
28. Park JE, Beal I, Dilworth JP, Tormey V, Haddock J. The HRCT appearances of granulomatous pulmonary disease in common variable immune deficiency. Eur J Radiol. 2005;54:359-364.
29. Sleasman JW. The association between immunodeficiency and the development of autoimmune disease. Adv Dent Res. 1996;10:57-61.
30. Sordet C, Cantagrel A, Schaeverbeke T, Sibilia J. Bone and joint disease associated with primary immune deficiencies. Joint Bone Spine. 2005;72: 503-514.
31. Spickett G, Prentice AG, Wallington T, Webster AD, Chapel H. Alopecia totalis and vitiligo in common variable immunodeficiency. Postgrad Med J. 1991;67:291-294.
32. Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CTscan findings. Q J Med. 2002;95:655-662.
33. Langley R, Krueger G, Griffiths CEM. Psoriatic arthritis and psoriasis: classification, clinical features, pathophysiology, immunology, genetics, epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64:18-23.
34. Psaila B, Bussel JB. Immune thrombocytopenic purpura. Hematol Oncol Clin North Am. 2007;21: 743-759.
35. Bates C, Ellison MC, Lynch DA, Cool CD. Brown KK, Routes JM. Granulomatous lymphocytic lung disease shortens survival in CVID. J Allergy Clin Immunol. 2004;114:415-421.
36. Wheat W, Cool SD, Morimoto Y, et al. Possible role of human herpes virus 8 in the lymphoproliferative disorders in CVIDs. J Exp Med. 2005;202: 479-484.
37. Aghamohammadi A, Pouladi N, Parvaneh N, et al. Mortality and morbidity in common variable immunodeficiency. J Trap Pediatr. 2007;53:32-38.
38. Seymour B, Miles J, Haeney M. Primary antibody deficiency and diagnostic delay. J Clin Path. 2005;58:546-547.
39. Ogershok P, Hogan MB, Welch JE, Corder WT, Wilson NW. Spectrum of illness in pediatric common variable immunodeficiency. Ann Allergy Asthma Immunol. 2006;97:653-656.
40. Salzer U, Grimbacher B. Common variable immunodeficiency: the power of co-stimulation. Semin Immunol. 2006;18:337-346.
41. Wehr C, Kivioja T, Schmitt C, et al. The EUROclass trial: Defining subgroups in common variable immunodeficiency. Blood. 2008;111;77-85.
42. Fevang B, Ynestad A, Sandberg WJ, et al. Low numbers of regulatory T cells in CVID: association with chronic inflammation. Clin Exp Immunol. 2007;147:521-525.